title: Primary thyroid marginal zone B-cell lymphoma MALT-type in a patient with rheumatoid arthritis.
abstract: Autoimmune diseases are defined as specific, adapted immune reactions against self antigens. Immune mechanism deficiency is a causal factor for B-cell lymphoma in primary Sjögren's syndrome and autoimmune thyroid disease. Thyroid mucosa-associated lymphoid tissue (MALT) lymphoma is a 67-fold and parotid lymphoma is a 44-fold increased risk in Sjögren's syndrome and thyroiditis. MALT lymphoma was not reported in rheumatoid arthritis. We herein report the case of a 56-year-old woman with maltoma of thyroid in rheumatoid arthritis patient.
authors.affiliation: Division of Hematology, Department of Internal Medicine, Hacettepe University Hospital, Sihhiye, 06100, Ankara, Turkey. dr.songul1978@yahoo.com
authors.forename: Songul
authors.initials: S
authors.lastname: Serefhanoglu
authors.forename: Umit
authors.initials: U
authors.lastname: Tapan
authors.forename: Ihsan
authors.initials: I
authors.lastname: Ertenli
authors.forename: Umut
authors.initials: U
authors.lastname: Kalyoncu
authors.forename: Aysegul
authors.initials: A
authors.lastname: Uner
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004198:Disease Susceptibility; D005260:Female; D006044:Goiter, Nodular / Q000150:complications; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D013964:Thyroid Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D013965:Thyroidectomy; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone
references.citation: Ann Rheum Dis. 2005 May;64(5):699-703
references.pmid: 15695534
references.citation: Thyroid. 1993 Summer;3(2):93-9
references.pmid: 8369658
references.citation: Curr Treat Options Oncol. 2004 Aug;5(4):307-13
references.pmid: 15233907
references.citation: Blood. 2003 Oct 15;102(8):2741-5
references.pmid: 12842999
references.citation: Rheumatology (Oxford). 2000 Feb;39(2):185-8
references.pmid: 10725070
references.citation: J Clin Endocrinol Metab. 2002 Jan;87(1):105-11
references.pmid: 11788631
references.citation: Clin Rheumatol. 2007 Oct;26(10):1601-6
references.pmid: 17558463
references.citation: Ann Rheum Dis. 2005 Oct;64(10):1414-20
references.pmid: 15843454
references.citation: Ann Rheum Dis. 2006 May;65(5):617-22
references.pmid: 16249224
references.citation: Bull Soc Belge Ophtalmol. 1994;254:125-32
references.pmid: 7493112
references.citation: Blood. 2002 Jun 1;99(11):3909-15
references.pmid: 12010788
references.citation: J Clin Oncol. 2003 Nov 15;21(22):4157-64
references.pmid: 14615444
references.citation: Pneumonol Alergol Pol. 2000;68(5-6):265-72
references.pmid: 11004866
references.citation: J Korean Med Sci. 2003 Dec;18(6):897-900
references.pmid: 14676452
references.citation: J Clin Oncol. 2000 Sep;18(17):3135-43
references.pmid: 10963642
references.citation: Cancer. 1999 Dec 25;87(6):325-45
references.pmid: 10603186
references.citation: Cancer. 1994 Jan 1;73(1):200-6
references.pmid: 8275426
references.citation: World J Surg. 2007 May;31(5):978-86
references.pmid: 17235456
references.citation: Am J Surg Pathol. 2000 May;24(5):623-39
references.pmid: 10800981